Inherently targeted estradiol-derived carbon dots for selective killing of ER (+) breast cancer cells via oridonin-triggered p53 pathway activation

被引:0
|
作者
Khan, Aftab Hossain [1 ]
Basak, Ambalika [1 ]
Zaman, Afreen [1 ]
Das, Prasanta Kumar [1 ]
机构
[1] Indian Assoc Cultivat Sci, Sch Biol Sci, Kolkata 700032, India
关键词
QUANTUM DOTS; NANOPARTICLES; DELIVERY; DOXORUBICIN; ARREST; INHIBITION; RECEPTOR; RELEASE;
D O I
10.1039/d4tb01415d
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
One of the most prevalent cancers globally is breast cancer and approximately two thirds of the breast cancers are hormone receptor positive with estrogen receptors (ER) being a prominent target. Notably, p53 that controls several cellular functions and prevents tumor formation, gets suppressed in breast cancers. Reactivation of p53 can lead to cell cycle arrest as well as apoptosis. Therefore, targeting the estrogen receptor for selective delivery of anticancer drugs that can reactivate p53 in ER (+) breast cancers can be a crucial method in breast cancer therapy. Herein, we have designed and developed estradiol-derived inherently targeted specific carbon dots (E-2-CA-CD) from 17 beta-estradiol and citric acid following a solvothermal method. The synthesized carbon dots were characterized using spectroscopic and microscopic techniques. The water soluble, intrinsically fluorescent E-2-CA-CD showed excellent biocompatibility in MCF-7, MDA-MB-231 as well as NIH3T3 cells and demonstrated target specific bioimaging in ER (+) MCF-7 cells due to the overexpressed ER receptors. Furthermore, oridonin, a well-known hydrophobic anticancer drug capable of upregulating the p53 pathway, was loaded on the carbon dots to increase its bioavailability. E-2-CA-CD-Ori caused similar to 2.2 times higher killing in ER (+) MCF-7 cells compared to ER (-) MDA-MB-231 cells and normal cells NIH3T3. Also, E-2-CA-CD-Ori showed similar to 3 fold better killing in MCF-7 cells compared to native oridonin. E-2-CA-CD-Ori-induced killing of MCF-7 cells took place through the early to late apoptotic pathway along with the elevation of the intracellular ROS level. Importantly, E-2-CA-CD-Ori triggered the activation of the p53 pathway in MCF-7 cells, which in turn induced apoptosis involving the upregulation of Bax and downregulation of Bcl-2 leading to the selective and efficient killing of ER (+) MCF-7 cells.
引用
收藏
页码:11708 / 11720
页数:13
相关论文
共 50 条
  • [31] Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation
    Yin, M.
    Ren, X.
    Zhang, X.
    Luo, Y.
    Wang, G.
    Huang, K.
    Feng, S.
    Bao, X.
    Huang, K.
    He, X.
    Liang, P.
    Wang, Z.
    Tang, H.
    He, J.
    Zhang, B.
    ONCOGENE, 2015, 34 (06) : 691 - 703
  • [32] ERβ modulates genistein's cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway
    Liu, Ren
    Xu, Xiaolin
    Liang, Chenglin
    Chen, Xin
    Yu, Xiaowei
    Zhong, Hongfei
    Xu, Wenxiu
    Cheng, Yu
    Wang, Wei
    Wu, Yudong
    Yu, Lehan
    Hu, Xiaojuan
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2019, 456 (1-2) : 205 - 216
  • [33] ERβ modulates genistein’s cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway
    Ren Liu
    Xiaolin Xu
    Chenglin Liang
    Xin Chen
    Xiaowei Yu
    Hongfei Zhong
    Wenxiu Xu
    Yu Cheng
    Wei Wang
    Yudong Wu
    Lehan Yu
    Xiaojuan Hu
    Molecular and Cellular Biochemistry, 2019, 456 : 205 - 216
  • [34] Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation
    Zhou, Qianqian
    Song, Chao
    Liu, Xiaoqiu
    Qin, Hao
    Miao, Lixia
    Zhang, Xuesen
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 625 - 636
  • [35] Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway
    Yuan, Sujuan
    Qiao, Tankui
    Li, Xuan
    Zhuang, Xibing
    Chen, Wei
    Chen, Xue
    Zhang, Qi
    ONCOLOGY LETTERS, 2018, 15 (04) : 5271 - 5279
  • [36] Curcumol triggers apoptosis of p53 mutant triple-negative human breast cancer MDA-MB 231 cells via activation of p73 and PUMA
    Huang, Lanzhen
    Li, Ang
    Liao, Guanzhen
    Yang, Feicheng
    Yang, Jing
    Chen, Xu
    Jiang, Xiaoshan
    ONCOLOGY LETTERS, 2017, 14 (01) : 1080 - 1088
  • [37] Octahedral Pt(IV) complex K101 induces apoptosis via ERK1/2 activation and the p53 pathway in human colon cancer cells
    Kwon, Young-Ee
    Kim, Kuk-Hwan
    ANTI-CANCER DRUGS, 2006, 17 (05) : 553 - 558
  • [38] Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231
    Meng, Chao
    Song, Linlin
    Wang, Juan
    Li, Di
    Liu, Yanhong
    Cui, Xiaoguang
    ONCOLOGY REPORTS, 2017, 37 (02) : 841 - 848
  • [39] Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells
    Seo, Hye-Sook
    Choi, Han-Seok
    Kim, Soon-Re
    Choi, Youn Kyung
    Woo, Sang-Mi
    Shin, Incheol
    Woo, Jong-Kyu
    Park, Sang-Yoon
    Shin, Yong Cheol
    Ko, Seong-Kyu
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 366 (1-2) : 319 - 334
  • [40] Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway
    Beberok, Artur
    Wrzesniok, Dorota
    Rok, Jakub
    Rzepka, Zuzanna
    Respondek, Michalina
    Buszman, Ewa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (05) : 1727 - 1737